217 related articles for article (PubMed ID: 34612593)
1. Prognostic factors and survival prediction in HER2-positive breast cancer with bone metastases: A retrospective cohort study.
Lyu X; Luo B
Cancer Med; 2021 Nov; 10(22):8114-8126. PubMed ID: 34612593
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and survival prediction of young breast cancer patients with liver metastases: a population-based study.
Pu CC; Yin L; Yan JM
Front Endocrinol (Lausanne); 2023; 14():1158759. PubMed ID: 37424855
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a SEER-based prognostic nomogram for patients with bone metastatic prostate cancer.
Hou G; Zheng Y; Wei D; Li X; Wang F; Tian J; Zhang G; Yan F; Zhu Z; Meng P; Yuan J; Gao M; Li Z; Zhang B; Xing Z; Yuan J
Medicine (Baltimore); 2019 Sep; 98(39):e17197. PubMed ID: 31574827
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a risk stratification nomogram for predicting prognosis in bone metastatic breast cancer: A population-based study.
Hou N; Yi J; Wang Z; Yang L; Wu Y; Huang M; Hou G; Ling R
Medicine (Baltimore); 2021 Feb; 100(6):e24751. PubMed ID: 33578627
[TBL] [Abstract][Full Text] [Related]
5. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
Wang B; Wang S; Ren W
BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
8. Prognostic nomogram for patients with non-metastatic HER2 positive breast cancer in a prospective cohort.
Luo C; Zhong X; Wang Z; Wang Y; Wang Y; He P; Peng Q; Zheng H
Int J Biol Markers; 2019 Mar; 34(1):41-46. PubMed ID: 30852974
[TBL] [Abstract][Full Text] [Related]
9. Surgery for primary tumor benefits survival for breast cancer patients with bone metastases: a large cohort retrospective study.
Huang Z; Zhou X; Tong Y; Zhu L; Zhao R; Huang X
BMC Cancer; 2021 Mar; 21(1):222. PubMed ID: 33663462
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in gastric cancer with multi-organ metastases.
Wang T; Liu C; Wang W; Huang B; Yu R; Huang M; Dong W
Transl Cancer Res; 2022 Jun; 11(6):1534-1551. PubMed ID: 35836507
[TBL] [Abstract][Full Text] [Related]
11. Establishment and Validation of Novel Clinical Prognosis Nomograms for Luminal A Breast Cancer Patients with Bone Metastasis.
Tu Q; Hu C; Zhang H; Peng C; Kong M; Song M; Zhao C; Wang Y; Li J; Zhou C; Wang C; Ma X
Biomed Res Int; 2020; 2020():1972064. PubMed ID: 33490234
[TBL] [Abstract][Full Text] [Related]
12. Construction and validation of nomogram for the cancer-specific mortality for HER2-positive breast cancer patients.
Wu N
Medicine (Baltimore); 2024 Mar; 103(11):e37330. PubMed ID: 38489717
[TBL] [Abstract][Full Text] [Related]
13. Independent risk factors evaluation for overall survival and cancer-specific survival in thyroid cancer patients with bone metastasis: A study for construction and validation of the predictive nomogram.
Tong Y; Huang Z; Hu C; Chi C; Lv M; Li P; Zhao C; Song Y
Medicine (Baltimore); 2020 Sep; 99(36):e21802. PubMed ID: 32899008
[TBL] [Abstract][Full Text] [Related]
14. Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis.
Gong Y; Zhang J; Ji P; Ling H; Hu X; Shao ZM
Cancer Med; 2018 Aug; 7(8):4156-4169. PubMed ID: 29984914
[TBL] [Abstract][Full Text] [Related]
15. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
[TBL] [Abstract][Full Text] [Related]
16. Prognostic nomogram for colorectal cancer patients with multi-organ metastases: a Surveillance, Epidemiology, and End Results program database analysis.
Tang X; Hu N; Huang S; Jiang J; Rao H; Yang X; Yuan Y; Zhang Y; Xia G
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12131-12143. PubMed ID: 37428251
[TBL] [Abstract][Full Text] [Related]
17. Web-Based Dynamic Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Breast Cancer Patients with Lung Metastases.
Wang K; Li Y; Wang D; Zhou Z
J Pers Med; 2022 Dec; 13(1):. PubMed ID: 36675704
[TBL] [Abstract][Full Text] [Related]
18. Prognostic nomogram for female patients suffering from non-metastatic Her2 positive breast cancer: A SEER-based study.
Wu J; Xie Z; Xiao Y; Wang B; Zhang P
Medicine (Baltimore); 2022 Oct; 101(40):e30922. PubMed ID: 36221419
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.
Yin F; Wang S; Hou C; Zhang Y; Yang Z; Wang X
Front Public Health; 2022; 10():969030. PubMed ID: 36203704
[TBL] [Abstract][Full Text] [Related]
20. Prognosticators and Prognostic Nomograms for Leiomyosarcoma Patients With Metastasis.
Zou Y; Yang Q; Wu Y; Ai H; Yao Z; Zhang C; Luo F
Front Oncol; 2022; 12():840962. PubMed ID: 35372053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
